• Hospital Quality Of Infection Control

    Nov 1, 2014, 00:00

  • Alcohol Consumption- the Burden of Entourage

    Nov 1, 2014, 00:00

  • History of Antidepressant use Among Primary Care Depressed Patients Switching Treatments in the United Kingdom

    Nov 1, 2014, 00:00

  • Burden of Disease Analysis of Psoriatic Arthritis In Hungary

    Nov 1, 2014, 00:00

  • Rehabilitation In Resurfacing Hip Arthroplasty Patients- Preliminary Cost-Effectiveness Results From A Clinical Trial

    Nov 1, 2014, 00:00

  • A macro Economic Analysis of 65 Year-Old 'Rendez-vous Vaccinal 'in Fran What is the Return on Investment?

    Nov 1, 2014, 00:00

  • Are There Any Commonalities In Payer Requirements and Reimbursement Pathways for Medical Devices in the Dach (Germany, Austria, Switzerland) Region?

    Nov 1, 2014, 00:00

  • Health Care Resource Use and Cost Of Multiple Sclerosis in Slovakia- Results from the National Cross-Sectional Study

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Community-Acquired Pneumonia Treatment

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Telaprevir Triple Therapy in Treatment of Naïve Chronic Hepatitis C Patients In Turkey

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Subcutaneous Immunothereapy in Allergic Rhinitis Using One or More Allergens - An Analysis Long Overdue

    Nov 1, 2014, 00:00

  • Do health technology agencies accept methods for dealing with treatment switching?

    Nov 1, 2014, 00:00

  • Recruiting Myelofibrosis Patients for Clinical and Health Outcome Studies Using Managed Physician Panels in 5 EU Countries

    Nov 1, 2014, 00:00

  • Systematic Review Of Mathematical Models Predicting Relative Effectiveness

    Nov 1, 2014, 00:00

  • Application Of Medicines Scoring System (Medss) - Potential Savings Through Drug Formulary Review Of Sulphonylureas

    Nov 1, 2014, 00:00

  • Management of Type 2 Diabetes Mellitus Among Patients Attending a Primary Health Care Setting in Qatar- A Study on Medication Use Pattern and Clinical Outcomes

    Nov 1, 2014, 00:00

  • Regulatory Approval to Patient Access, an Evaluation of EU5 and us National Timing Differences

    Nov 1, 2014, 00:00

  • Cost-Effectiveness and Budget-Impact Analysis of Braf Inhibitors in Patients With Metastatic Malignant Melanoma (MMM) in Slovenia

    Nov 1, 2014, 00:00

  • Validity And Responsiveness Of The Bristol Rheumatoid Arthritis Fatigue Multidimensional Questionnaire (BRAF-MDQ) In A Randomized Controlled Clinical Trial

    Nov 1, 2014, 00:00

  • Outcomes in Severe Osteoporotic Women in Korea Using Sequential Treatment

    Nov 1, 2014, 00:00

  • Goal Directed Perfusion (Gdp)- A Differential Cost Analysis In Uk And Us

    Nov 1, 2014, 00:00

  • Long-Term Costs and Consequences of Patients with Familial Chylomicronemia Syndrome – A Simulation Model Approach

    Nov 1, 2014, 00:00

  • Treatment Patterns and Costs Of Neoadjuvant Systemic Therapies (NAT) For Early Breast Cancer (EBC)- A Retrospective Claims Analysis

    Nov 1, 2014, 00:00

  • Are antibiotic Policies and Reimbursement Decisions Aligned?

    Nov 1, 2014, 00:00

  • Managed-Entry Agreements- Possible Options for Vaccines?

    Nov 1, 2014, 00:00

  • The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland

    Nov 1, 2014, 00:00

  • Economic Impact of Dengue Episode- Multicenter Study Across Four Brazilian Regions

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Ingenolo Mebutato Verse Imiquimod in the Treatment of Actinic Keratoses in the Perspective of the Italian Health System

    Nov 1, 2014, 00:00

  • Critical Evaluation of Labeling Requirements of Nutraceutical Brands

    Nov 1, 2014, 00:00

  • Humanistic Research Outcomes in Multiple Sclerosis- Review of the Literature from Latin America

    Nov 1, 2014, 00:00

  • The Greek Health Care Reform After Troika's Involvement- The Potential Impact on Global Pricing and Access Strategy

    Nov 1, 2014, 00:00

  • Efficiency Of Rehabilitation Programs For Patients After Traumatic Brain Injury And Acute Cerebrovascular Accident (Stroke) In Russia

    Nov 1, 2014, 00:00

  • Risk of Relapse Among Propensity Score Matched Multiple Sclerosis Patients Receiving Natalizumab or Platform Therapy in the US

    Nov 1, 2014, 00:00

  • Estimating Smoking Cessation Rates and Smoking Prevalences Using Public Data and a Published Dynamic Model

    Nov 1, 2014, 00:00

  • The Prevalence of Hypoglycemia and Its Impact on The Quality of Life of Type 2 Diabetes Mellitus Patients in Greece (The Hypo Study)

    Nov 1, 2014, 00:00

  • Relationship Between Microbiological Eradication and Clinical Outcome with Antibiotic Treatment in Nosocomial Pneumonia, Complicated Urinary Tract Infection, and Complicated Intra-Abdominal Infection

    Nov 1, 2014, 00:00

  • Effect of Pharmaceutical Care on the Quality of Life in the Patients of Coronary Artery Disease

    Nov 1, 2014, 00:00

  • Patient-Reported Medical Expenditures For Insulin-Treated Diabetes Patients In Eastern, Central And Western Regions Of China

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Canagliflozin Verse Insulin-Secretagogues (Sulphonylureas) or Insulin In Patients With Type 2 Diabetes Mellitus (T2dm) As An Add-On To Metformin In Ireland

    Nov 1, 2014, 00:00

  • Antenatal Depression and Its Risk Factors Among Women in Chengdu of China Results From A Hospital Based Survey

    Nov 1, 2014, 00:00

  • Development Of A Model To Assess The Cost-Effectiveness Of Therapies For Patients With Type 2 Diabetes Mellitus (T2DM) Following A Reference Model Framework

    Nov 1, 2014, 00:00

  • Determination of Cost-Effectiveness Threshold For Malaysia

    Nov 1, 2014, 00:00

  • Nub Status - A 2014 Situation Analysis for Drugs- Oncology As Leading Therapeutic Area

    Nov 1, 2014, 00:00

  • When Gender Matters- Impact of Fda Safety Warning on Dispensed Zolpidem Dose

    Nov 1, 2014, 00:00

  • Systematic Review and Critical Appraisal of the Statistical Methods Used in Published Studies To Indirectly Compare Novel Anticoagulants (Noacs) With Warfarin for the Prevention of Stroke in Patients With Atrial Fibrillation (Af)

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Everolimus for the Treatment of Hormone Receptor Positive, Human Epidermal Growth Factor Receptor-2 Negative (HER2-) Advanced Breast Cancer in Kazakhstan

    Nov 1, 2014, 00:00

  • Impact of Pulmonary Exacerbations On Eq-5d Measures In Patients With Cystic Fibrosis

    Nov 1, 2014, 00:00

  • Cultural Adaptation of the Alcohol Quality of Life Scale for Use in Japan, China, and Korea

    Nov 1, 2014, 00:00

  • Prevalence-Based Measurement of the Economic Burden of Rare Diseases- Case Review To Determine the Annual Cost of Acromegaly In France

    Nov 1, 2014, 00:00

  • Sagit©- A Novel Clinician-Reported Outcome for Managing Acromegaly in Clinical Practice

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Endobronchial Valve Therapy for Severe Emphysema- A Model-Based Projection Based on the Vent Study

    Nov 1, 2014, 00:00

  • Subjective Expectations Regarding Life Expectancy And Health-Related Quality Of Life In Moderate To Severe Psoriasis Patients

    Nov 1, 2014, 00:00

  • Pricing of Medicines In Poland – Two-Year Overview Of How The New Law Affected Costs Of Reimbursement

    Nov 1, 2014, 00:00

  • Knowledge Transfer Gap Between Cardiologists and Patients Undergoing Percutaneous Coronary Intervention Regarding Risks Associated With Drug-Eluting Stents- An Asian European Survey

    Nov 1, 2014, 00:00

  • Burden Associated with Agitation in Schizophrenia

    Nov 1, 2014, 00:00

  • Clnical Management Of Non-Valvular Atrial Fibrillation In Hong Kong

    Nov 1, 2014, 00:00

  • DISCRETE-CHOICE EXPERIMENT VERSE RATING SCALE EXERCISE TO EVALUATE THE RELATIVE IMPORTANCE OF ATTRIBUTES- A STUDY OF THE MAASTRICHT ISPOR STUDENT CHAPTER

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Apixaban Compared To Other Anticoagulants For Lifetime Treatment And Prevention Of Recurrent Venous Thromboembolism

    Nov 1, 2014, 00:00

  • Cost-Analysis of Chronic Idiopathic Urticaria Disease

    Nov 1, 2014, 00:00

  • Budget Impact of Left Atrial Appendage Occulusion in Patients with Atrial Fibrillation Contraindicated to Anticoagulation

    Nov 1, 2014, 00:00

  • Allocating Vaccine Funds for Pneumococcal Vaccination of Infants and Older Adults- A Method for Strategic Evaluation in the Netherlands

    Nov 1, 2014, 00:00

  • Evaluation of Use of Belimumab In Clinical Practice Settings (Observe Study) In Spain- Health Resource Utilization and Labour Absenteeism

    Nov 1, 2014, 00:00

  • Prostate Cancer Overall Survival- Multilevel Analysis of A Population-Based Cancer Registry Data

    Nov 1, 2014, 00:00

  • Assessing the Impact of Pharmacist Maldistribution on Self-Reported Health in Rural and Urban Counties in the us

    Nov 1, 2014, 00:00

  • Burden Of Cardiovascular Complications In Patients With Atrial Fibrillation In France

    Nov 1, 2014, 00:00

  • Workflow Mapping for Paediatric Vaccination Process in the United Kingdom (Uk)- A Precursor of A Time and Motion (TM) Study

    Nov 1, 2014, 00:00

  • Treatment Patterns Among Type 2 Diabetes Mellitus Patients in Saudi Arabia

    Nov 1, 2014, 00:00

  • A Method to Investigate Seasonal Variation in Hospitalization for Copd in A Midwestern US State

    Nov 1, 2014, 00:00

  • Investigating the use of Personalised Medicine in Cancer Trials – an Update

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Evaluation of Data from the Evidence (Evidence of Interferon Dose-Response- European North American Comparative Efficacy) Study

    Nov 1, 2014, 00:00

  • An Electronic Version of the Pdq-39- Acceptability To Respondents and Assessment of Alternative Response formats

    Nov 1, 2014, 00:00

  • The Impact of Psychological Treatment of Rheumatic Patients With Mental Health

    Nov 1, 2014, 00:00

  • Hta Status of Biosimlars Across the UK and Ireland

    Nov 1, 2014, 00:00

  • Impact of Hypoglycemia on Discontinuing or Down-Titrating Sulfonylurea Among Type 2 Diabetes Patients Without Insulin

    Nov 1, 2014, 00:00

  • Comparative Pharmacoeconomic Analysis of the Application of Posaconazole, Fluconazole and Itraconazole With the Purpose of Primary Prevention of Invasive Fungal Infection In Patients With Neutropenia During Chemotherapy for Acute Myelogenou ...

    Nov 1, 2014, 00:00

  • A Retrospective, Longitudinal Study to Investigate the Change of LDL-C Level and Pharmaceutical Intervention by Using Japanese Health Care Checkup Database

    Nov 1, 2014, 00:00

  • Characteristics of The Medicines Which Have Annual Average Highest Amount Of Sales Of Between Years 2008-2013

    Nov 1, 2014, 00:00

  • Alzheimer's Disease- Medication Costs and Impact of Generic Substitution

    Nov 1, 2014, 00:00

  • Common Illnesses Identified by Community Health Workers in the Households and Referrred to Primary Health Facilities For Care

    Nov 1, 2014, 00:00

  • Community Pharmacists Attitude and Perceived Need Towards the Provision of Pharmaceutical Care Services- A Qualitative Approach

    Nov 1, 2014, 00:00

  • Elicitation of Health State Utilities Associated with Varying Severities of Flare in Systemic Lupus Erythematosus

    Nov 1, 2014, 00:00

  • The Oncotyrol Prostate Cancer Outcome and Policy Model - How Latent Prevalence Affects the Benefit-Harm Balance of Screening

    Nov 1, 2014, 00:00

  • An Evidence-Based Model Design to Inform the Cost-Effectiveness Evaluation of Primary Endocrine Therapy And Surgery for Older Women with Primary Breast Cancer

    Nov 1, 2014, 00:00

  • Health Care Resource Utilization (HCRU) In Hospitalized Febrile Neutropenia (FN) Patients Treated With Chemotherapy For Solid Tumors (ST) And Hematological Malignancies (HM) In Bulgaria

    Nov 1, 2014, 00:00

  • Challenges and Opportunities in the Malaysian Health Care System

    Nov 1, 2014, 00:00

  • A Network Meta-Analysis Comparing the Efficacy And Safety of Ceftobiprole and Selected Comparators in the Treatment of Hospital-Acquired Pneumonia

    Nov 1, 2014, 00:00

  • Influenza Vaccination in China Among the Urban Population and High-Risk Groups

    Nov 1, 2014, 00:00

  • Economic Evaluation of the Fixed Dose Combination of Indacaterol/ Glycopyrromium, as a Maintenance Bronchodilator Treatment in Adult Mexican Patients With COPD

    Nov 1, 2014, 00:00

  • Prescribing Patterns and Expenditures for Otitis Media-Related Antibiotics for Children in the Texas Medicaid Program

    Nov 1, 2014, 00:00

  • Do the Us Panel Recommendations Hold for Europe? Investigating the Relation Between Quality of Life Versus Work-Status, Absenteeism and Presenteeism

    Nov 1, 2014, 00:00

  • Population Access to Rotavirus Vaccination in Industrialized Countries- Lessons Learnt from Current Experience

    Nov 1, 2014, 00:00

  • Type of Multimorbidity and Patient-Centered Care Among Elderly Medicare Beneficiaries

    Nov 1, 2014, 00:00

  • Computerised Cognitive Behaviour Therapy for Depression Management- A Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of 13-Valent Versus 10-Valent Pneumococcal Conjugate Vaccine Use in Croatia National Vaccination Program

    Nov 1, 2014, 00:00

  • The Risk of Metabolic Disorders in Patients Treated with Asenapine or Olanzapine- A Real World Data Study Conducted in Italy and Spain

    Nov 1, 2014, 00:00

  • Fixed Dose Combinations of Nucleoside Reverse Transcriptase Inhibitor for Naïve Patient with Hiv Infection in Russia- Cost Comparison Analysis

    Nov 1, 2014, 00:00

  • Cost and Quantity Characteristics of Medical Devices In Slovakia

    Nov 1, 2014, 00:00

  • The Irish Cost-Effectiveness Threshold- Does It Support Rational Rationing or Might It Lead To Systematic Damage Of Ireland's Health System?

    Nov 1, 2014, 00:00

  • Economic Impact of Clinical Researches to the Research Centers and Reimbursement Systems in Turkey

    Nov 1, 2014, 00:00

  • Health Related Quality of Life and Patient Satisfaction in Colorectal Cancer Patients Treated Through Radical Surgery in Curative Intent in a Colo-Proctology Clinical Department

    Nov 1, 2014, 00:00

  • Comparison of Medical Costs and Utilization Associated With Use of Ziprasidone and Olanzapine Among Schizophrenia and Bipolar Disorder Patients

    Nov 1, 2014, 00:00

  • The Societal Costs of Schizophrenia in Switzerland

    Nov 1, 2014, 00:00

  • Patients' Preferences for Bone Metastases Treatments in Turkey

    Nov 1, 2014, 00:00

  • Direct and Indirect Cost of HCV-Related Diseases in Italy- An Incidence-Based Probabilistic Approach

    Nov 1, 2014, 00:00

  • Towards Universal Health Care- A Review of the Basic Basket of Care Associated With Universal Health Care Delivery Models

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Subcutaneous Verse Intramuscular Interferon Beta-1A In Portugal Based on the Findings of Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Economic Evaluation of Catheter-Based Renal Denervation for Patients with Resistant Hypertension in Korea

    Nov 1, 2014, 00:00

  • The Economic Cost Of Urinary Tract Infections In The Community- Results From Ireland

    Nov 1, 2014, 00:00

  • Impact of Pharmacoeconomics Guidelines on the International Publications in China

    Nov 1, 2014, 00:00

  • Redel Study- Differences in Reimbursement Delays in Cee Countries

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of 1-Year Adjuvant Trastuzumab Therapy of Early-Stage Her2-Positive Breast Cancer

    Nov 1, 2014, 00:00

  • Health Economic Model for Novel in Vitro Diagnostic Kit for Infective Endocarditis

    Nov 1, 2014, 00:00

  • Policy Evaluation of Anti-Hypertensive Drugs in Mumbai, India

    Nov 1, 2014, 00:00

  • Monitoring Antiretroviral Therapy in Uganda- Budget Impact Analysis of Two Strategies for Viral Load Monitoring Versus Immunologic Monitoring

    Nov 1, 2014, 00:00

  • Prescribing Patterns and Treatment Outcomes in North Indian Female Patients with Chronic Low Back Pain

    Nov 1, 2014, 00:00

  • Trend in Prevalence and Distribution of Diabetes Mellitus Type I and Type II in the Netherlands

    Nov 1, 2014, 00:00

  • A Cost-Effectiveness Analysis of Treatment for Mild to Moderate Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) in France

    Nov 1, 2014, 00:00

  • Health Care Costs and Utilization of U. S. Veteran Patients Diagnosed with Pancreatic Cancer

    Nov 1, 2014, 00:00

  • Clinical Research for the Effectiveness and Economic Value of Qinxitong in the Patients with Ra in China

    Nov 1, 2014, 00:00

  • New Meta-Analysis of Patient-Level Data on Efficacy And Hypoglycaemia with Insulin Glargine or Nph Insulin in Type 2 Diabetes Mellitus (T2DM) According to Concomitant Oral Therapy

    Nov 1, 2014, 00:00

  • Cost Consequence Model Investigating the Impact of Bowel Cleansing on Prevention of Colorectal Cancer in a German Screening Population

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of the Use of Crizotinib for Non-Small Cell Lung Cancer and ALK+ Mutation in the Two Main Public Health Care Institutions in Mexico

    Nov 1, 2014, 00:00

  • Acceptance Of Telemonitoring By Health Care Professionals in Germany- A Question Of Financial Conditions

    Nov 1, 2014, 00:00

  • Non-Treatment Specific Parameter Value Estimates- Relationship Between BMI and Utility

    Nov 1, 2014, 00:00

  • Database Analysis On Patients Using Immunobiological Drugs In A Brazilian Private Health Care Plan- A Real World Data Analysis

    Nov 1, 2014, 00:00

  • Over the Counter Medication and Dietary Supplements Use Among Older Adults

    Nov 1, 2014, 00:00

  • A Spanish Cost-Effectiveness Analysis Of Sevelamer Versus Calcium Carbonate In Nondialysis-Dependent Chronic Kidney Disease (Ckd) Patients

    Nov 1, 2014, 00:00

  • Medium Term Avoided Costs- High-Dose Hypoallergenic House Dust Mite Preparation Immunotherapy Verse Conventional Symptomatic Treatment

    Nov 1, 2014, 00:00

  • Individualised Growth Response Optimisation (IGRO)- A Multi-Language Software Medical Device to Predict Growth Response in Children Treated With Growth Hormone (GH)

    Nov 1, 2014, 00:00

  • Testing The Utility Of The Nhs's Systemic Anti-Cancer Therapy Data Set For Multi-Indication Pricing

    Nov 1, 2014, 00:00

  • An Examination of the Regulatory and Reimbursement Processes for Biobetters and Comparison With Biosimilars

    Nov 1, 2014, 00:00

  • Predictive Modelling for Optimal Target Population and Real-World Study Design- An Example In Mother-To-Child Transmission of HIV

    Nov 1, 2014, 00:00

  • Evaluating The Long-Term Cost-Effectiveness Of Liraglutide 1.2 Mg And Exenatide In Patients With Type 2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Restless Leg Syndrome Detection in Hemodialysis

    Nov 1, 2014, 00:00

  • Aging Impact Over the National Health Cost in Extremadura Public Health Expenditure of Extremadura in the Period 2011-21

    Nov 1, 2014, 00:00

  • Reimbursed Pharmacotherapy of Metastatic Clear Cell Kidney Cancer (MCCKC) in the Czech Republic

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Capsaicin 8% Patch (Qutenzatm) Compared With Pregabalin for the Treatment of Patients With Peripheral Neuropathic Pain (Pnp) In Scotland

    Nov 1, 2014, 00:00

  • A Reliability Generalisation of the Eortc Qlq-Br23

    Nov 1, 2014, 00:00

  • Effects of A Multidisciplinary Home-Based Medication Review Program On Hospital Admissions In Older Adult Singaporeans

    Nov 1, 2014, 00:00

  • Pregnancy Outcomes in Women with Inflammatory Bowel Syndrome Following Exposure to Thiopurines and Anti-Tumor Necrosis Factor Drugs- A Meta-Analysis and Systematic Review

    Nov 1, 2014, 00:00

  • Expanded Data Sets For Hta Decision-Making In Oncology- Do They Help To Achieve Positive Appraisals?

    Nov 1, 2014, 00:00

  • A Quantification of Expenditure on Hospital Stays In 5 European Countries

    Nov 1, 2014, 00:00

  • Clinical and Cost-Effectiveness and Budget Impact of Routine Use of Bispectral Index Monitors In Theatres

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Maintenance Treatment With Rituximab In Patients With Follicular Lymphoma Responding To First Line Induction Therapy In Portugal

    Nov 1, 2014, 00:00

  • Comparison of the Valuation of Treatment Alternatives in Parkinson's Disease with Best-Worst Scaling, Time Trade-off and Visual Analogue Scales

    Nov 1, 2014, 00:00

  • Pollen Morphology and Total Protein of Taraxacum Officinale and Aster Alpinus

    Nov 1, 2014, 00:00

  • Orphan Drug Approvals In Europe- Historical Review and Trends

    Nov 1, 2014, 00:00

  • General Beliefs About Medicines Among Depressed Patients in Saudi Arabia

    Nov 1, 2014, 00:00

  • A Comparison of Value for Health States Worse Than Dead Between Japan and Uk

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Grounding Of Using Polypill Amlodipine With Atorvastatin Versus Monodrugs In Patients With Hypertension And Dyslipidemia In Ukraine

    Nov 1, 2014, 00:00

  • Examination of the Efficiency of Electrical Stimulation in Case of Stress and Urge Incontinence

    Nov 1, 2014, 00:00

  • A Cost-Effectiveness Analysis of EGFR-TK Mutation Status-Guided 1st- and 2nd-Line Treatment of Stage III/IV Non-Small Cell Lung Cancer in the UK

    Nov 1, 2014, 00:00

  • Effectiveness, Safety and Patients' Subjective Feelings of Insulin Pen-Needle- A Systematic Review

    Nov 1, 2014, 00:00

  • Economic Assessment of Preeclampsia- Screening, Diagnosis, Treatment Options, and Long Term Outcomes, A Systematic Review

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Evaluation and Burden of Illness of Acute Exacerbation of Copd in Patients in Malaysia

    Nov 1, 2014, 00:00

  • Impact of Copayment Reduction or Exemption Programme on Generic Drug Utilisation- the Specified Disease Treatment Research Programme in Japan

    Nov 1, 2014, 00:00

  • Investigating the Impact of Perspective on Weighting Qalys- a Discrete Choice Experiment

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Saxagliptin Compared To Glp-1 Analogues As An Add-On To Insulin in the Treatment of Type 2 Diabetes Mellitus From A Uk Health Care Perspective

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Strontium Ranelate Verse Alendronate for Management of Osteoporosis Among Post-Menopausal Women in Malaysia Using A Markov Modelling Approach

    Nov 1, 2014, 00:00

  • The Influence Of Gene Expression Profiling (GEP) On Decisional Conflict In Chemotherapy Treatment Decision-Making For Early-Stage Breast Cancer (BRCA)

    Nov 1, 2014, 00:00

  • Prescribing Pattern of Anti-Emetics for Prevention of Chemotherapy Induced Nausea Vomiting—An Observation of Clinical Practice Versus Standard Guidelines

    Nov 1, 2014, 00:00

  • A Comparison of Three Language Versions of the EQ-5D-5L Dimension Scales in Singapore

    Nov 1, 2014, 00:00

  • Social Aspects of HCV Treatment In Kazakhstan

    Nov 1, 2014, 00:00

  • Claims Reimbursement Analysis of the National Health Insurance Scheme in Ghana

    Nov 1, 2014, 00:00

  • Medical Expenditure For People With Diabetes In Urban Employee Basic Medical Insurance For Hebei Provincial Institutes

    Nov 1, 2014, 00:00

  • Development Of A Global Economic Model To Evaluate The Cost-Effectiveness Of Targeted Treatments Using Companion Diagnostics In Advanced/Metastatic Cancer Treatment

    Nov 1, 2014, 00:00

  • Efficacy, Effectiveness and the “Efficacy-To-Effectiveness Gap”- Review of the Current State of Play and Perspectives. First Results From the Imi Getreal Consortium

    Nov 1, 2014, 00:00

  • Health-Economic Comparison of Sensor-Augmented Pump With Low Glucose Suspend Versus Insulin Pump Alone For The Treatment Of Hypo-Prone Type 1 Diabetes In Slovakia

    Nov 1, 2014, 00:00

  • COST-EFFECTIVENESS OF POST-THERAPY PET AND TELEPHONE INTERVIEW IN THE CLINICAL FOLLOW-UP OF PATIENTS TREATED WITH LOCALLY ADVANCED CERVICAL CANCER

    Nov 1, 2014, 00:00

  • Long-Term Grading of Health-Related Quality of Life of Care-Needed Elderly- A 2-Yr Follow-Up Study

    Nov 1, 2014, 00:00

  • The Burden of Non-Small Cells Lung Cancer (NSCLC) in First Line (1L) Treatment- Patterns of Care and Cost of Illness

    Nov 1, 2014, 00:00

  • The Importance of Sensitivity Analysis in Assessing Clinical and Economic Impact of National Immunization Programs- An Example of Slovenia

    Nov 1, 2014, 00:00

  • Type 2 Diabetes Treatment Patterns Across Europe

    Nov 1, 2014, 00:00

  • A Review Of Cost Of Illness Studies In Patients With End Stage Renal Disease

    Nov 1, 2014, 00:00

  • Comparison of Resource use and Health Care Costs in New Initiators of Long-Acting Injectable (Lai) and Oral Second Generation Antipsychotics

    Nov 1, 2014, 00:00

  • The Patient Experience of Alcohol use Disorder

    Nov 1, 2014, 00:00

  • Early Retirement Indirect Costs Attributable to Rheumatic Diseases in Portugal

    Nov 1, 2014, 00:00

  • The Economic Burden of Systemic Lupus Erythematosus- A Structured Literature Review

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Radical Prostatectomy, Radiation Therapy and Active Surveillance for the Treatment of Localized Prostate Cancer – A Claims Data Analysis

    Nov 1, 2014, 00:00

  • Estimating Means from Medians- A Case Study With Treatments for Metastatic Colorectal Cancer (MCRC)

    Nov 1, 2014, 00:00

  • A Real-World Characterization of Patients With “Moderate-To-Severe” Systemic Lupus Erythematosus

    Nov 1, 2014, 00:00

  • Interventions and Policy Measures in Health Care And Pharmaceutical Sector To Increase Effeciency And Recovery of Greek Health Care System

    Nov 1, 2014, 00:00

  • Economic Analysis Of Thrombo Incode, A Clinical-Genetic Function For Assessing The Risk Of Venous Thromboembolism

    Nov 1, 2014, 00:00

  • Correlation of Recent HTA Decisions Between Taiwan and Korea- Implication for Launch Strategies

    Nov 1, 2014, 00:00

  • Assessment of Utilities in Japan- Data Availability and Methodology

    Nov 1, 2014, 00:00

  • Prevalence Of Symptoms And Cluster Analysis In Dialysis Patients Using Kdqol-36

    Nov 1, 2014, 00:00

  • An Archetype For Classification and Comparison of Hta Activities in Latin America

    Nov 1, 2014, 00:00

  • Impacts Of Bar-Code Medication Administration (Bcma) On Patients' Safety in Taiwan

    Nov 1, 2014, 00:00

  • Simulating Individual Patient Level Data To Address Treatment Switching When Only Summary Data Are Available

    Nov 1, 2014, 00:00

  • Evaluation of Estimators of Treatment Effect in Observational Studies

    Nov 1, 2014, 00:00

  • Cost Effectiveness of Quadrivalent Influenza Vaccine Over Trivalent Vaccine in France

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Real-Time Medication Monitoring in Children with Asthma

    Nov 1, 2014, 00:00

  • Skeletal-Related Events (SRES) Impact Significantly the Health-Related Quality of Life (HRQOL) of Chemo-Naive Men With Metastatic Castration Resistant Prostate Cancer (MCRPC)

    Nov 1, 2014, 00:00

  • Evaluation of Methods for the Inclusion of Real World Evidence in Network Meta-Analysis – A Case Study in Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Public Beliefs and Attitudes about Schizophrenia, Major Depression and Psychotropic Medication in Tunisia

    Nov 1, 2014, 00:00

  • The Cost Burden of Switching Patients with Relapsing-Remitting Multiple Sclerosis from Glatiramer Acetate To Newly-Approved Disease Modifying Therapies

    Nov 1, 2014, 00:00

  • What The English Could Learn From The Irish- Making The Nice Approval Process More Cost-Effective

    Nov 1, 2014, 00:00

  • The Use of Integrated Concept Mapping to Develop the Dementia Care Model by Community Participation

    Nov 1, 2014, 00:00

  • Example of Analysis Utilizing Real World Data- Medical Cost Reduction by Advising Untreated-Hypertension Patients to Visit Doctors

    Nov 1, 2014, 00:00

  • Economic Comparison of Empirical Versus Diagonstic-Driven Strategies for Immunocompromised Patients with Suspected Fungal Infection Results from a Chinese Payer Perspective

    Nov 1, 2014, 00:00

  • C5a Receptor Antagonist Protects Mice from Uropathogenic Escherichia Coli-Induced Kidney Infection

    Nov 1, 2014, 00:00

  • Prescription Practices for Uncomplicated Malaria at two Public Health Facilities in Nigeria; A Descriptive, Comparative Study

    Nov 1, 2014, 00:00

  • Assessment of Need, Development and Implementation of Supportive Management Database for the Treatment of Poisoning Cases in a Tertiary Care Hospital

    Nov 1, 2014, 00:00

  • Atomoxetine for the Treatment of Newly Diagnosed Adults with Adhd - a Cost Effectiveness Analysis in Spain

    Nov 1, 2014, 00:00

  • Long Term Follow up of Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients- “Real-World” Data from the Island of Crete

    Nov 1, 2014, 00:00

  • Nab-Paclitaxel or Docetaxel as Alternatives to Solvent-Based Paclitaxel in Metastatic Breast Cancer (Mbc)- A Cost Utility Analysis from a Chinese Health Care Perspective

    Nov 1, 2014, 00:00

  • The Effects of Gallium Chloride on Apoptosis Osteoporosis Model of Rats Caused by Tretinoin Acid

    Nov 1, 2014, 00:00

  • Cost-Benefit Model of Varying Nexplanon and Other Long-Acting Reversible Contraceptive (Larc) Methods- Uptake Compared to the Oral Contraceptive Pill- UK Perspective

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Certolizumab Pegol in the Management of Patients With Moderate-To-Severe Active Rheumatoid Arthritis in Greece

    Nov 1, 2014, 00:00

  • Potential Monetary Value of Human Papillomavirus Vaccination on Human Papillomavirus-Related Cancers and Genital Warts in the United Kingdom

    Nov 1, 2014, 00:00

  • All-Cause Mortality Validation of the Core Diabetes Model Against Predictions of the Charlson Comorbidity Index

    Nov 1, 2014, 00:00

  • The Impact Of Pharmaceutical Policies On Pharmaceutical Sales Patterns In Sweden And Japan

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Palivizumab Use in High Risk Children From Brazilian Health System Perspective

    Nov 1, 2014, 00:00

  • Prevalence of Febrile Neutropenia in Breast Cancer Patients Received Adjuvant Paclitaxel Treatment

    Nov 1, 2014, 00:00

  • HEALTH ECONOMIC EVALUATION OF DIAGNOSTIC AND PROGNOSTIC PREDICTION MODELS. A SYSTEMATIC REVIEW

    Nov 1, 2014, 00:00

  • Impact Of International And Therapeutic Referencing On Prices And Launch Optimization

    Nov 1, 2014, 00:00

  • Efficacy and Safety of Human Insulin Versus Animal Insulin Among Patients with Diabetes in China- A Meta-Analysis

    Nov 1, 2014, 00:00

  • Time to Reimbursement for Oncology Agents from EMA Marketing Authorization to AIFA Approval AS “C(NN)” Class versus. AIFA Approval AS “A” or “H” Class

    Nov 1, 2014, 00:00

  • Exploring Uncertainty in Economic Evaluation Of Medicines- A Review of The First Manufacturers' Submissions To the French National Authority For Health (Has)

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Of Saxagliptin When Added To Metformin And Sulphonylurea In The Treatment Of Type 2 Diabetes Mellitus In Spain

    Nov 1, 2014, 00:00

  • The Humanistic and Economic Burden of Partial Onset Seizures in the Europe Five and Brazil Using a Patient Survey

    Nov 1, 2014, 00:00

  • Health Economics Evaluation for Insulin Injection Pen-Needle with Different Lengths in Patients With Diabetes in China

    Nov 1, 2014, 00:00

  • Factors Conditioning Health Related Quality Of Life In Patients With Psoriasis In Europe- A Systematic Review Of The Literature

    Nov 1, 2014, 00:00

  • Efficacy and Hospitalization Length of Stay of Single Dose Oritavancin Compared to 7-10 Days of Vancomycin in Patients with Acute Bacterial Skin and Skin Structure Infections in the Us and Eastern Europe

    Nov 1, 2014, 00:00

  • Bayesian Models for Cost-Effectiveness Analysis in the Presence of Structural Zero Costs

    Nov 1, 2014, 00:00

  • Access to Asthma Medicines in Tehran; Iran

    Nov 1, 2014, 00:00

  • Direct Costs of Treatment of Skin Drug Reactions Induced by Antibiotics in Perspective of Public Payer and Service Provider

    Nov 1, 2014, 00:00

  • A Cost Utility Analysis of Amlodipine Compared with Angiotensin II Receptor Blockers in Preventing Stroke and Myocardial Infarction Among Hypertension Patients in the Philippines

    Nov 1, 2014, 00:00

  • Discontinuities Between Health Technology Assessment (HTA) and Health Care Service Objectives of the NHS

    Nov 1, 2014, 00:00

  • The Budget Impact of Duoresp® Spiromax® (Budesonide + Formoterol Fumarate Dihydrate) Compared With Symbicort® Turbohaler® for the Management of Asthma and Chronic Obstructive Pulmonary Disease in the United Kingdom- Impact on Health Care Co ...

    Nov 1, 2014, 00:00

  • The Dynamics Of Prices And Quantities Of New Drugs Under Taiwan's National Health Insurance Program

    Nov 1, 2014, 00:00

  • Significant and Meaningful Improvement in Treatment Satisfaction with Teriflunomide Versus Subcutaneous IFNB-1A in Patients with Relapsing MS Results from Tenere

    Nov 1, 2014, 00:00

  • A Double-Blind Controlled Study of the Efficacy and Safety of Long-Acting Amfepramone Treatment In Mexican Obese Patients

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis Of Carotid Artery Stenting Versus Endarterectomy For Symptomatic Carotid Stenosis Patients

    Nov 1, 2014, 00:00

  • Apoptosis and Oxidative Stress Induced By Exposure of Microwave Radiation In Rat Thymus- Modulatory Effect of Melatonin

    Nov 1, 2014, 00:00

  • The Burden Of Primary Hyperhidrosis On The Patient- Eq-5d-5l Utilities, Willingness To Pay And Daily Time Spent In Managing The Condition

    Nov 1, 2014, 00:00

  • Modeling to Predict Severe Maternal Morbidity Based on 33993 Deliveries of Registered Study in China

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Ranolazine For The Treatment Of Angina Pectoris In Russia

    Nov 1, 2014, 00:00

  • Patient Reported Outcomes(Pros) in Patients with Lower Urinary Track Symptom(Luts)/Benign Prostatic Hyperplasia(Bph) Accompanied with Overactive Bladder(Oab) in Korea

    Nov 1, 2014, 00:00

  • ECOA Licensing- Lessons Learned from the Copyright of COA Translations and Specificities of ECOAS

    Nov 1, 2014, 00:00

  • Symtomatic Factors in Patients With Major Depressive Disorder (MDD)- Results from an Observational Study

    Nov 1, 2014, 00:00

  • Impact of Medication Adherence by Using Indian Version Compliance Questionnaire Rheumatology (Cqr) and Medication Adherence Report Scale (Mars) Tools on Quality of Life of Patients With Rheumatoid Arthritis

    Nov 1, 2014, 00:00

  • Feasibility of A Network Meta-Analysis in Endometriosis

    Nov 1, 2014, 00:00

  • The Performance of the Pragmatic Strategy to Bring in Pharmacoeconomic Evidence for Drugs Reimbursement Decisions in Taiwan

    Nov 1, 2014, 00:00

  • Effectiveness of Catheter-Based Renal Denervation for Treatment Resistant Hypertension – Results of a Systematic Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • Closing the Gap- Reduced Delay to Drug Marketing Approval Between The West and Asia

    Nov 1, 2014, 00:00

  • Psychometric Evaluation Of The Patient's Knee Implant Performance (PKIP) Questionnaire For The Assessment Of Primary Total Knee Arthroplasty

    Nov 1, 2014, 00:00

  • Development of a Conceptual Model for Pediatric Oncology Results from a Review of Qualitative Research Literature and Clinician Interviews

    Nov 1, 2014, 00:00

  • Possibilities of Breast Cancer Prevention

    Nov 1, 2014, 00:00

  • Is Chinese Syndrome Necessary in the Effectiveness Evaluation of Chinese Herbal Formulas?

    Nov 1, 2014, 00:00

  • Complications, costs And Resource Utilization in Real-World Complex Abdominal Wall Reconstruction Patients

    Nov 1, 2014, 00:00

  • The Costs of Diagnosis and Treatment of Ankle Sprains and Fractures, 1980-2013- A Systematic Review

    Nov 1, 2014, 00:00

  • Estimation of Costs Associated With Cardiovascular Complications of Diabetic Patients In Madrid (Spain) Using A New Simulation Model

    Nov 1, 2014, 00:00

  • Prevalence of Neuropathic Pain and Its Disease Burden In Korea Patients With Lumbar Spine Surgery

    Nov 1, 2014, 00:00

  • Anticipated Price Disclosure- Impact on Funding Decisions in Australia

    Nov 1, 2014, 00:00

  • Evaluating the Translatability of Physical Assessment Clinical Outcomes Assessment (Coa) Items

    Nov 1, 2014, 00:00

  • Self-Reported Frequency and Impact of Non-Severe Hypoglycaemia in Insulin-Treated Adults in the UK

    Nov 1, 2014, 00:00

  • Symptom Burden and Health Related Quality of Life in Patients With Idiopathic Pulmonary Fibrosis in Clinical Practi Insights-Ipf Registry

    Nov 1, 2014, 00:00

  • Linking Health Care Administrative Databases And National Registry Data In Order To Monitor Icd Therapy In Italy

    Nov 1, 2014, 00:00

  • The Impact of Disease Modification on the Cost-Effectiveness of Pegloticase for the Treatment of Severe Debilitating Chronic Tophaceous Gout In Adult Patients

    Nov 1, 2014, 00:00

  • Prevalence-Based Measurement of the Economic Burden of Rare Diseases- Case Review To Determine the Annual Cost of Acromegaly In Italy

    Nov 1, 2014, 00:00

  • Patient, Insuree and Public Participation in Health Technology Assessment- An International Comparison

    Nov 1, 2014, 00:00

  • Translation and Validation of Kidney Disease and Quality of Life (Kdqol-Sftm 1.2) Instrument to Measure Health Related Quality of Life Of Indian Patients with Kidney Disease

    Nov 1, 2014, 00:00

  • Is it Possible to Predict The Market Access of a New Pharmaceutical in Germany? A Systematic Evaluation of Federal Joint Committee Decisions on Early Benefit Assessments According to The German Law For Reforming The Market of Pharmaceutical ...

    Nov 1, 2014, 00:00

  • Survival or Mortality- Framing of the Risk Attribute in a Discrete Choice Experiment

    Nov 1, 2014, 00:00

  • Long-Term Trends in Breast Cancer Epidemiology in the Slovak Republic

    Nov 1, 2014, 00:00

  • Quality of Life (Qol) With Psoriasis- Ethnography Study Evaluating the Impact of Psoriasis On Moderate To Severe Patients In Europe (Eu), From A Patient's Perspective

    Nov 1, 2014, 00:00

  • Costs of Employees with Treatment-Resistant Depression Based on a Canadian Private Claims Database

    Nov 1, 2014, 00:00

  • Impact of Vaccination- Health Impact and Cost-Effectiveness to Make Informed Policy Decision on the Introduction of Human Papillomavirus (Hpv) Vaccine to the National Immunization Program (Nip) in Thailand

    Nov 1, 2014, 00:00

  • The Relationship Between Macular Edema and Health Outcomes Among Patients With Diabetes in Western Europe

    Nov 1, 2014, 00:00

  • The Impact Of Drug Price Control Policy For Diabetes Medication- A Longitudinal Analysis In Taiwan

    Nov 1, 2014, 00:00

  • Do HTA Processes Correlate With Reimbursement Recommendations?

    Nov 1, 2014, 00:00

  • Cost of a Pulmonary Arterial Hypertension-Related Hospitalization in Belgium

    Nov 1, 2014, 00:00

  • Upfront Overall Survival Modelling in Comparison to Real World Data- Lenalidomide for the Treatment of Multiple Myeloma Patients in South Korea

    Nov 1, 2014, 00:00

  • Population Health- Mental Health of us Veterans by Benefits Enrollment Status

    Nov 1, 2014, 00:00

  • An Analysis Of The Utilization Of Cephalosporins From 2007 To 2011 In Guangdong Province Of China

    Nov 1, 2014, 00:00

  • Cost-Utility of Cancer Therapies – the 'Cost' of Different Utility Generation Strategies

    Nov 1, 2014, 00:00

  • Age and Gender Distribution of Outpatient Care Physiotherapy Services for Cerebral Palsy and Other Paralytic Syndromes in Hungary

    Nov 1, 2014, 00:00

  • Epidemiology and Severity of Chronic Obstructive Pulmonary Disease (COPD) in the United Kingdom (UK)

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Drugs for Ultra-Rare Non-Oncological Diseases In Europe

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Maternal Immunisation for Pertussis in New Zealand

    Nov 1, 2014, 00:00

  • Hand Hygiene Compliance or the Influencing Factors of Efficiency in the Scope of Students

    Nov 1, 2014, 00:00

  • The Impact of the Information System of Medical Devices in Portugal

    Nov 1, 2014, 00:00

  • Disease Burden of Unintended Pregnancy in China

    Nov 1, 2014, 00:00

  • Had the Individual Medical Burden of Basic Health Insurance Participants Really Been Alleviated in 2009-2012?

    Nov 1, 2014, 00:00

  • Translation and Linguistic Validation of the Electronic Colombia Suicide Severity Rating Scale in Asia-Pac

    Nov 1, 2014, 00:00

  • Orphan and Rare Diseases - the Payer Perspective

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Exenatide Twice Daily (Bid) Added To Basal Insulin Compared To A Bolus Insulin Add-On In Turkey

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Evaluation of Treatment With Tocilizumab in Russian Children With Systemic Juvenile Idiopathic Arthritis

    Nov 1, 2014, 00:00

  • Prospective Study on the Average Cost of Therapy for Bronchial Asthma Patients in an Indian Tertiary Care Teaching Hospital

    Nov 1, 2014, 00:00

  • Forecasting Outpatient Pharmaceutical Expenditure for Cancer Treatment in Germany

    Nov 1, 2014, 00:00

  • Patients' Preferences in Oral Diabetes Treatment- A Discrete Choice Experiment in Type2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Health Care-Associated Infection Prevalence Among Grade a Tertiary Hospitals in China- A Meta-Analysis

    Nov 1, 2014, 00:00

  • Cost-Minimisation Analysis of Dapagliflozin Compared To Lixisenatide As An Add-On To Insulin In The Treatment of Type 2 Diabetes Mellitus From A Uk Health Care Perspective

    Nov 1, 2014, 00:00

  • Potential Cost-Effectiveness Of Therapeutic Drug Monitoring In Patients With Resistant Hypertension

    Nov 1, 2014, 00:00

  • The Possibility of Initiating True Risk-Sharing Agreements in the Current Economic Situation

    Nov 1, 2014, 00:00

  • Critical Review of Cost-Effectiveness Analyses (CEA) of Prevention Strategies Against Diseases Associated with Human Papillomavirus (HPV) Infection

    Nov 1, 2014, 00:00

  • Global HTA Assessments of Ultra-Orphan Products- A Case Study Of Eculizumab (Soliris) and Iduronate-2-Sulfatase (Elaprase)

    Nov 1, 2014, 00:00

  • An Observational Propensity Score-Matched Study to Evaluate Cost-Effectiveness of a Real-Time Pcr-Based Assay in Patients with Suspected Sepsisk

    Nov 1, 2014, 00:00

  • Economic Impact of New Rural Cooperative Medical Scheme In China

    Nov 1, 2014, 00:00

  • Long-Term Outcomes of Ledipasvir/Sofosbuvir (LDV/ SOF) for the Treatment of Chronic Hepatitis C Infected (HCV) Genotype 1 Patients in the UK

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Brentuximab Vedotin in Hodgkin Lymphoma in Sweden

    Nov 1, 2014, 00:00

  • Impact of Drug Policy Regulations on the Consumption of Antihypertensive Drugs in Slovakia

    Nov 1, 2014, 00:00

  • How Iranian People Think About Generic Substitution?

    Nov 1, 2014, 00:00

  • Costs Associated with the Use of Enzyme-Inducing Anti-Epileptic Drugs Versus Non-Enzyme-Inducing Anti-Epileptic Drugs- A Systematic Review

    Nov 1, 2014, 00:00

  • Comparative Effectiveness Study of Enzymatic Replacement Therapies In the Treatment of Gaucherxs Disease On Adults

    Nov 1, 2014, 00:00

  • Impact of Demographics on Health Preferences in China- An Exploratory Analysis of China EQ-5D-5L Valuation Study

    Nov 1, 2014, 00:00

  • Implementation of International Chart Review Studies- An Assessment of Ethics and Regulatory Considerations

    Nov 1, 2014, 00:00

  • The Impact of Different Levels of Clinical Pharmacist Interventions on the Therapeutic Plan and Cost Saving

    Nov 1, 2014, 00:00

  • Cost-Minimization Analysis of Trastuzumab Intravenous Versus Trastuzumab Subcutaneous for the Treatment of Patients With HER2+ Early Breast Cancer And Metastatic Breast Cancer in Greece

    Nov 1, 2014, 00:00

  • Effect of A Pharmacy-Based Diabetes Management Program on Glycemic Control in an Inpatient General Medicine Population

    Nov 1, 2014, 00:00

  • Impact of Omalizumab on Poor Asthma Control Events and Medication Utilisation in Patients With Moderate or Severe Persistent Asthma

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Canagliflozin In The Treatment of Type 2 Diabetes Mellitus In Norway

    Nov 1, 2014, 00:00

  • Using The Ispor 2013 European Congress as a Big Data Case Study

    Nov 1, 2014, 00:00

  • Evidence for Regional Variation in the Appraisal of Individual Cancer Drugs Fund Requests

    Nov 1, 2014, 00:00

  • A Comparison of Market Access Evaluations for new Oncology Therapies in France, Germany and the UK- An Analysis Using the Prismaccess Database

    Nov 1, 2014, 00:00

  • The Relationship Between Masked Hypertension and Obesity

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Model Results of Intrathecal Baclofen Therapy Compared to Conventional Medical Management in Patients with Non-Focal Disabling Spasticity Who are Resistant or Intolerant to Oral Therapy at the Institut Guttmann

    Nov 1, 2014, 00:00

  • Analysis on Policies of Biosimilar Market in China

    Nov 1, 2014, 00:00

  • Cost Comparison of Surgical and Non-Surgical Treated Lumbar Spinal Stenosis Patients

    Nov 1, 2014, 00:00

  • Estimating The Value Of Cangrelor From Eliminating Preloading In Coronary Artery Bypass Graft (Cabg) Patients

    Nov 1, 2014, 00:00

  • Innovation May Drive Streamlined Access to New Biopharmaceuticals Across Some Emea Markets

    Nov 1, 2014, 00:00

  • Direct Health Care Costs Associated With Opioid-Induced Constipation

    Nov 1, 2014, 00:00

  • Clinical Effectiveness of Fumaric Acid Esters (Fumaderm) in Psoriasis- A Systematic Review of Literature

    Nov 1, 2014, 00:00

  • Burden of Non-Adherence To Type 1 Diabetes Mellitus Therapeutic Guidelines In France

    Nov 1, 2014, 00:00

  • The Impact of Treatment of Thyreoid Disease in Pregnant Women to the Outcome of Giving Birth

    Nov 1, 2014, 00:00

  • Validation of the SPHR Diabetes Prevention Model

    Nov 1, 2014, 00:00

  • The Burden of Myelofibrosis In Greece

    Nov 1, 2014, 00:00

  • The Costs of Major and Minor Cycling Accidents in Tasmania, Australia

    Nov 1, 2014, 00:00

  • Public Health and Economic Impact of Vaccinating Children with a Quadrivalent live Attenuated Influenza Vaccine in France Using a Dynamic Transmission Model

    Nov 1, 2014, 00:00

  • State of the Art Research In Austria- Dexhelpp - Decision Support For Health Policy and Planning- Methods, Models and Technologies Based On Existing Health Care Data

    Nov 1, 2014, 00:00

  • Minimum Clinically Important Difference in the Global Assessment Functioning in Patients with Schizophrenia

    Nov 1, 2014, 00:00

  • Price Variation in Obstetrical Services in A Rural State

    Nov 1, 2014, 00:00

  • Comparing the Efficacy of Anti-Vascular Endothelia Growth Factor Drugs for Treatment of Age-Related Macular Degeneration- a Clinical Literature Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • Economic Impact Model of Breast Cancer Treatment at Early Stages in the Mexican Public Health Care Sector

    Nov 1, 2014, 00:00

  • Effect Of Sample Size And Data Maturity On Parametric Survival Modeling Projections In Advanced Cancer

    Nov 1, 2014, 00:00

  • An Efficient Design for Cost-Effectiveness Studies of Personalized Medicine Strategies

    Nov 1, 2014, 00:00

  • Incidence and Prevalence of COPD By Gold 2013 Classification in the Netherlands

    Nov 1, 2014, 00:00

  • Bevacizumab for Metastatic Colorectal Cancer- A Literature Review on Meta-Analyses and Cost-Effectiveness Analyses

    Nov 1, 2014, 00:00

  • Literature Review of Decision-Analytical Models Used in the Economic Evaluation of Empirical/Targeted Antifungal Treatments for Invasive Fungal Infections

    Nov 1, 2014, 00:00

  • Pro Claims In Orphan Medicines Approved By the European Medicines Agency (Ema) for the Treatment of Lymphoproliferative Disorders

    Nov 1, 2014, 00:00

  • Application of A Model Of Decision Based on Fuzzy Logic to Pharmacoeconomics- Treatment of CROHN'S Disease With Antitnf in Out of Label Use

    Nov 1, 2014, 00:00

  • Cost Effectiveness Of Solifenacin Compared With Oral Antimuscarinic Agents For The Treatment Of Patients With Overactive Bladder (Oab) In The Uk

    Nov 1, 2014, 00:00

  • Adherence to Nice Guidance For Initiating Glp-1 Mimetics Among Patients With Type 2 Diabetes In Primary Care In England And Wales - An Evaluation Using The Clinical Practice Research Datalink (Cprd)

    Nov 1, 2014, 00:00

  • Impact of Allergen Immunotherapy on Quality of Life and Health Care Costs in Adults and Children With Grass Pollen-Induced Allergic Rhinitis in Germany

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Analysis of Oral Capecitabine and Tegafur for Colorectal Cancer Treatment in Russia

    Nov 1, 2014, 00:00

  • Using an Innovative Approach to Build a Prospective Diabetes Cohort Registry of Patients With Type 2 Diabetes in Germany- DIAREG

    Nov 1, 2014, 00:00

  • Use of Services and Cost of Agitation and Containment in Psychiatric Hospitals- a Systematic Review

    Nov 1, 2014, 00:00

  • Mapping European Database Usage- An Analysis of Published Data Types

    Nov 1, 2014, 00:00

  • Carer Perceived Burden as a Predictor of Health-Related Quality of Life- The Case of Colorectal Cancer

    Nov 1, 2014, 00:00

  • To Study the Treatment Pattern and Cost of Illness in Bipolar Disorder Patients in Tertiary Care Hospital in South India

    Nov 1, 2014, 00:00

  • Costs of Psoriasis in Europe. A Systematic Review of the Literature

    Nov 1, 2014, 00:00

  • Mast (Minimal Access Spinal Technologies) Versus Open Surgery- Cost Analysis From Hospital Perspective

    Nov 1, 2014, 00:00

  • Hospitalization Burden Among Dialysis Patients In Brazil- an Analysis of The Public Health System Database

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Ranibizumab Verse Aflibercept in Treatment of Treatment of Visual Impairment Due to Diabetic Macular Oedema (Dmo)

    Nov 1, 2014, 00:00

  • Ldl-C Goal Attainment In Patients With Hyperlipidemia - Estimates From Population-Based Register Data In Sweden

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Evaluation of Biologic Therapies in Russian Patients With Rheumatoid Arthritis and Intolerance or Inadequate Response to Conventional Basic Therap

    Nov 1, 2014, 00:00

  • HEALTH CARE RESOURCE USE AMONG ADVANCED GASTRIC CANCER PATIENTS IN TAIWAN AND SOUTH KOREA

    Nov 1, 2014, 00:00

  • Validation of The Hospital Episode Statistics Outpatient Dataset in England

    Nov 1, 2014, 00:00

  • Archimedes- A Large Scale Simulation System for Health Care Research and its Applications for Asian Countries

    Nov 1, 2014, 00:00

  • Treating Verse Non-Treating Obsturictive Sleep Apnea in Italy and Fran A Markov Model-Based Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness OF Canagliflozin (Cana) Versus Dapagliflozin (Dapa) In Patients With Type 2 Diabetes Mellitus (T2dm) With Inadequate Control On Metformin (Met) Monotherapy In The United Kingdom

    Nov 1, 2014, 00:00

  • Will Governments be Able to Afford a Cancer Cure Under Current Health Economic Evaluation Methods?

    Nov 1, 2014, 00:00

  • Prospective Study on Quality of Life (QOL) of Bronchial Asthma Patients in a Tertiary Care Teaching Hospital

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Surgical Management of Stress Urinary Incontinence With Single-Incision Mini-Sling Versus Tension-Free Vaginal Obturator in Spain

    Nov 1, 2014, 00:00

  • Implementation and Assessment of Periodic Safety Update Reporting System at Tertiary Care Teaching Hospital, Karnataka, India- A Drug Controller General of India Initiative

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Portugal

    Nov 1, 2014, 00:00

  • Methodological Requirements Regarding Quality of Life Measurement in the Early Assessment of Benefit In Germany

    Nov 1, 2014, 00:00

  • Adoption of Oral Disease Modifying Treatments to Manage Patients with Relapsing Remitting Multiple Sclerosis from 2011-2013 in the United States

    Nov 1, 2014, 00:00

  • Patient Experience With The Single-Use Pen For Injection of Once Weekly Dulaglutide in Injection-Naive Patients With Type 2 Diabetes

    Nov 1, 2014, 00:00

  • Hypertension Treatment in Chronic Kidney Disease Stage 3, 4 and 5- A Hospital Based Cross-Sectional Study in Malaysia

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Research and Application In 10 Asian Countries Between 2003 and 2013- A Systematic Review

    Nov 1, 2014, 00:00

  • Goal Attainment Scaling – A Useful Individualized Clinical Outcome Measure

    Nov 1, 2014, 00:00

  • Coping With A New Biologic Paradigm- Payer Strategies for the Purchasing of Complex Biosimilars

    Nov 1, 2014, 00:00

  • The Clinical Evidence Base of Treatment Options in Alzheimer's Disease- A Systematic Literature Search

    Nov 1, 2014, 00:00

  • Cost-Effectiveness and Value of Information Analyses of Nutritional Support in Preventing Pressure Ulcers in High Risk Hospitalised Patients

    Nov 1, 2014, 00:00

  • The Burden of Parkinson Disease Amongst Caregivers in Spain Over 4 Years

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Use of Dydrogesterone in Premenstrual Syndrome

    Nov 1, 2014, 00:00

  • Strategies To Overcome Hurdles In Hta Appraisals Amid Limitations Resulting From Single-Arm Trial Data

    Nov 1, 2014, 00:00

  • Proposal for a Comprehensive Definition of Budget Impact Analysis

    Nov 1, 2014, 00:00

  • Quality of Life in Patients With Lung Cancer in the Slovak Republic

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in the Republic of Panama, in Patients with Metastatic Castration-Resistant Prostate Cancer that Have Failed to Chemotherapy with Docetaxel

    Nov 1, 2014, 00:00

  • Potential Epidemics of Drugs Resistant Bacteria in Poverty Stricken Countries Like Pakistan

    Nov 1, 2014, 00:00

  • Setting up the Right Scenarios for Cost-Effectiveness Analysis- An Example with Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients in China

    Nov 1, 2014, 00:00

  • Review Of Reference Pricing Effects On Pharmaceuticals

    Nov 1, 2014, 00:00

  • Network Meta-Analysis With Baseline Risk Adjustment To Assess The Relative Efficacy Of Ustekinumab In Adult Patients With Active Psoriatic Arthritis

    Nov 1, 2014, 00:00

  • Development Of An Influenza Outbreak Forecasting Model Using Time Series Analysis Methods

    Nov 1, 2014, 00:00

  • What are the Lifelong costs of Vaccinating one Individual? The French Case

    Nov 1, 2014, 00:00

  • Awareness of Breast Cancer and its Prevention. A Comparative Survey Among Finnish and Hungarian Women

    Nov 1, 2014, 00:00

  • Cost-Effectiveness and Cost-Utility of Granulocyte Colony-Stimulating Factors in the Primary Prophylaxis of Chemotherapy Induced Febrile Neutropenia (FN) in Breast Cancer Patients in Gree A Comparative Analysis

    Nov 1, 2014, 00:00

  • Economic Impact of a Genomic Companion Diagnostic Test for Breast Cancer Patients in French Private Hospitals

    Nov 1, 2014, 00:00

  • Sofosbuvir For The Treatment Of Chronic Hepatitis C- A Comprehensive Cost-Effectiveness Analysis Across Hcv Genotypes, Pretreatment Conditions And Hiv Co-Infection

    Nov 1, 2014, 00:00

  • Feasibility of Conducting Retrospective Studies Using Hashtags and Social Media Data From Facebook and Twitter

    Nov 1, 2014, 00:00

  • Discrete Event Simulation For The Cost-Effectiveness Evaluation Of Pet-Ct Scans In The Diagnosis Of Conn's Disease In Hypertensive Patients

    Nov 1, 2014, 00:00

  • Health Care Costs in Patients With Type 2 Diabetes in Flanders Based on A Combination of Clinical And Health Insurance Data

    Nov 1, 2014, 00:00

  • A Comparison of International Health Technology Assessment Systems – Does The Perfect System Exist?

    Nov 1, 2014, 00:00

  • Physicians' and Patients' Preferences Over the Attributes of Biological Agents Used In the Treatment of Rheumatic Diseases In Spain- A Conjoint Analysis

    Nov 1, 2014, 00:00

  • Return on Investment of Preventively Vaccinating Health Care Workers Against Pertussis- A Dutch Case Study

    Nov 1, 2014, 00:00

  • Assessing Willigness to Pay Among Psoriasis and Psoriatic Arthritis Patients

    Nov 1, 2014, 00:00

  • Price Comparison Between the Essential and Non-Essential Anti-Infective Medicines Among National Reimbursement Drug List in China

    Nov 1, 2014, 00:00
  • «
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106 (current)
  • 107
  • 108
  • 109
  • 110
  • »